Lyme carditis with complete heart block: management with an external pacemaker.
Muhammad Ali Chaudhry1, Srinivasa D Satti1, Ira R Friedlander1
1Department of Cardiology and Electrophysiology Aultman Hospital Canton Ohio.
Clinical Case Reports
|June 8, 2017
Summary
Prompt diagnosis and treatment are crucial for Lyme carditis prognosis. Externalized pacemakers offer a feasible temporary solution for conduction blocks during antibiotic therapy.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Devices
Background:
- Lyme carditis, a serious manifestation of Lyme disease, can lead to significant cardiac conduction abnormalities.
- Early diagnosis and intervention are critical for improving patient outcomes in Lyme carditis.
Observation:
- This study evaluates the use of an externalized permanent pacemaker with an active fixation lead.
- The pacemaker served as a supportive pacing modality in patients with Lyme carditis.
Findings:
- The externalized pacemaker was found to be a feasible option for managing conduction blocks.
- This supportive measure was effective until the complete resolution of conduction abnormalities, alongside continued antibiotic treatment.
Implications:
- Externalized pacemakers provide a viable temporary solution for hemodynamic support in Lyme carditis.
- This approach facilitates continued antibiotic therapy and allows for natural recovery of cardiac conduction.
Related Concept Videos
Myocarditis III: Medical Management
266
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266
Dysrhythmias VI: Management of Dysrhythmias
545
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
545
Pericarditis III: Medical Management
438
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
438
Rheumatic Heart Disease III: Medical Management
422
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
422
Cardiomyopathy V: Interprofessional Care
551
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Cardiomyopathy II: Dilated Cardiomyopathy
673
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
673


